日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Robotic Transabdominal Preperitoneal Inguinal Hernia Repair Is Feasible and Efficient: A Prospective Cohort Study of a Day-Only Protocol From a High-Volume Robotic Surgery Centre Evaluating Short-Term Outcomes

机器人经腹膜前腹股沟疝修补术可行且有效:一项来自高容量机器人手术中心的单日手术方案的前瞻性队列研究评估了短期疗效

Choi, Joseph Do Woong; Bradford, Lauren; Tang, Kim; Bukofzer, Mark; Dunkin, Paul; Wong, Hannah; Ali-Beck, Ammar; Spillane, Andrew; Van Der Heever, Jennifer; Murphy, Catherine; Kueh, Julian; Woodman, Rennie; Needs, Aime; Fok, Kar Yin; Chen, Michelle; Zahid, Assad; Samra, Jaswinder; Lynch, Andrew Craig; Apostolou, Christos; Barto, Walid; Pillinger, Stephen

OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers

OCE-205,一种新型选择性血管加压素受体混合激动剂-拮抗剂:一项针对健康志愿者的 1 期研究的安全性、耐受性和药代动力学/药效学

Bagger, Yu; Ravis, William R; Harris, Geoff; Bukofzer, Stan

OCE-205 in rats and non-human primates: Pharmacokinetic and pharmacodynamic analysis

OCE-205 在大鼠和非人灵长类动物中的药代动力学和药效学分析

Bukofzer, Stan; Harris, Geoff; Cable, Edward E

OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension

OCE-205 是一种选择性 V1a 部分激动剂,可降低大鼠门静脉高压模型中的门静脉压力。

Bukofzer, Stan; Harris, Geoffrey; Song, Susan; Cable, Edward E

Empowering therapeutic antibodies with IFN-α for cancer immunotherapy

利用IFN-α增强治疗性抗体在癌症免疫治疗中的应用

Jun Guo ,Yu Xiao ,Ramesh Iyer ,Xin Lu ,Marc Lake ,Uri Ladror ,John Harlan ,Tanushree Samanta ,Medha Tomlinson ,Gail Bukofzer ,Cherrie Donawho ,Alex Shoemaker ,Tzu-Hsuan Huang

Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia

在急性肝损伤/衰竭和高氨血症患者中,L-鸟氨酸苯乙酸酯的安全性、耐受性和药代动力学研究

Stravitz, R Todd; Gottfried, Michelle; Durkalski, Valerie; Fontana, Robert J; Hanje, A James; Koch, David; Hameed, Bilal; Ganger, Daniel; Subramanian, Ram M; Bukofzer, Stan; Ravis, William R; Clasen, Kristen; Sherker, Averell; Little, Lanna; Lee, William M

Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig

利用半DVD-Ig实现强效且有条件的重定向T细胞杀伤肿瘤细胞

Bardwell, Philip D; Staron, Matthew M; Liu, Junjian; Tao, Qingfeng; Scesney, Susanne; Bukofzer, Gail; Rodriguez, Luis E; Choi, Chee-Ho; Wang, Jennifer; Chang, Qing; Dong, Feng; Donawho, Cherrie; Wang, Jieyi; Grinnell, Christine M; Tarcsa, Edit; Hutchins, Charles; Ghayur, Tariq; Gu, Jijie

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study

咖啡因对雷加德诺松药物负荷试验期间SPECT心肌灌注显像的影响:一项前瞻性、随机、多中心研究

Tejani, Furqan H; Thompson, Randall C; Kristy, Rita; Bukofzer, Stan

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

一项随机、双盲、安慰剂对照研究,旨在评估雷加德诺松在哮喘或慢性阻塞性肺疾病患者中的安全性和耐受性。

Prenner, Bruce M; Bukofzer, Stan; Behm, Sarah; Feaheny, Kathleen; McNutt, Bruce E

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

一项随机、双盲、安慰剂对照研究,旨在评估雷加德诺松在3期或4期慢性肾脏病患者中的安全性和耐受性。

Ananthasubramaniam, Karthik; Weiss, Robert; McNutt, Bruce; Klauke, Barbara; Feaheny, Kathleen; Bukofzer, Stan